Skip to main content
Equibles

STIFEL FINANCIAL CORP

Position in ABEO — Abeona Therapeutics Inc.

CIK 720672 ST. LOUIS, MO
Back to ABEO Full portfolio

Position in ABEO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$174,739
+$112,131 QoQ
Shares Held
28,275
+102.3% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 125 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $538,947,950 across 105 Biotechnology names. ABEO ranks #88 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BHVN
Biohaven Ltd.
 9,941,165 $147,924,534
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 162,151 $80,545,262
3 MANE
Veradermics, Inc
 294,117 $36,158,743
4 JAZZ
Jazz Pharmaceuticals plc
 139,491 $33,613,146
5 REGN
Regeneron Pharmaceuticals, Inc.
 46,378 $28,918,535
6 OMER
Omeros Corp
 1,836,925 $17,469,155
7 NTLA
Intellia Therapeutics, Inc.
 1,014,387 $17,163,427
8 IONS
Ionis Pharmaceuticals Inc
 202,983 $16,094,521

All Filings in ABEO

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $174,739 28,275
2026-03-31 $62,608 13,975